The (Garden) State of Life Sciences

Facts and figures• Employment: Compounded annual growth rate was 1.0% between 1990 and 2000-below the national average of 2.0%• Patents: 11.2 per 10,000 workers in 2000-above the national average of 7.5-but growth rate in the 1990s was 2.5% compared to 4.1% for the nation• Venture capital: Funding in 2002 was $106 per worker, slightly lower than the national average of $125• Fast-growth firms: NJ averaged 3.9% of all Inc500 fastest-growing firms between 1993–2002, c

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Employment: Compounded annual growth rate was 1.0% between 1990 and 2000-below the national average of 2.0%

Patents: 11.2 per 10,000 workers in 2000-above the national average of 7.5-but growth rate in the 1990s was 2.5% compared to 4.1% for the nation

Venture capital: Funding in 2002 was $106 per worker, slightly lower than the national average of $125

Fast-growth firms: NJ averaged 3.9% of all Inc500 fastest-growing firms between 1993–2002, compared to its share of 3.2% of nation's work force

Between 1990 and 2000, 5,403 net new jobs were added to the NJ life sciences industry. Some businesses fared better than others (each bar segment represents 1,000 jobs gained or lost):

Commercial phys./biol.research

Noncommercial research org.

Pharmaceutical preparations

Electromedical equipment

Patent owners and lessors

Diagnostic substances

Dental equipment/supplies

Biol. products, excl. diagnostic

X-ray apparatus and tubes

Surgical appliances and supplies

Ophthalmic goods

Plastics, bottles

Surgical and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Francesco Fiondella

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours